164 related articles for article (PubMed ID: 23835088)
1. Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study.
Kooistra M; Geerlings MI; Mali WP; Vincken KL; van der Graaf Y; Biessels GJ;
J Neurol Sci; 2013 Sep; 332(1-2):69-74. PubMed ID: 23835088
[TBL] [Abstract][Full Text] [Related]
2. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up.
van Elderen SG; de Roos A; de Craen AJ; Westendorp RG; Blauw GJ; Jukema JW; Bollen EL; Middelkoop HA; van Buchem MA; van der Grond J
Neurology; 2010 Sep; 75(11):997-1002. PubMed ID: 20837967
[TBL] [Abstract][Full Text] [Related]
3. Vascular brain lesions, brain atrophy, and cognitive decline. The Second Manifestations of ARTerial disease--Magnetic Resonance (SMART-MR) study.
Kooistra M; Geerlings MI; van der Graaf Y; Mali WP; Vincken KL; Kappelle LJ; Muller M; Biessels GJ;
Neurobiol Aging; 2014 Jan; 35(1):35-41. PubMed ID: 23932882
[TBL] [Abstract][Full Text] [Related]
4. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme and progression of white matter lesions and brain atrophy--the SMART-MR study.
Jochemsen HM; Geerlings MI; Grool AM; Vincken KL; Mali WP; van der Graaf Y; Muller M
J Alzheimers Dis; 2012; 29(1):39-49. PubMed ID: 22214784
[TBL] [Abstract][Full Text] [Related]
6. Physical activity, structural brain changes and cognitive decline. The SMART-MR study.
Kooistra M; Boss HM; van der Graaf Y; Kappelle LJ; Biessels GJ; Geerlings MI;
Atherosclerosis; 2014 May; 234(1):47-53. PubMed ID: 24607853
[TBL] [Abstract][Full Text] [Related]
7. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study.
Geerlings MI; Appelman AP; Vincken KL; Mali WP; van der Graaf Y;
Am J Epidemiol; 2009 Nov; 170(9):1147-55. PubMed ID: 19783584
[TBL] [Abstract][Full Text] [Related]
8. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease.
Ong M; Foo H; Chander RJ; Wen MC; Au WL; Sitoh YY; Tan L; Kandiah N
J Neurol Sci; 2017 Jun; 377():122-126. PubMed ID: 28477681
[TBL] [Abstract][Full Text] [Related]
9. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.
Grool AM; Gerritsen L; Zuithoff NP; Mali WP; van der Graaf Y; Geerlings MI
Biol Psychiatry; 2013 Jan; 73(2):169-76. PubMed ID: 23079234
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in brain volumes and cerebrovascular lesions on MRI in patients with manifest arterial disease: the SMART-MR study.
van der Veen PH; Muller M; Vincken KL; Witkamp TD; Mali WP; van der Graaf Y; Geerlings MI;
J Neurol Sci; 2014 Feb; 337(1-2):112-8. PubMed ID: 24314719
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine, progression of ventricular enlargement, and cognitive decline: the Second Manifestations of ARTerial disease-Magnetic Resonance study.
Jochemsen HM; Kloppenborg RP; de Groot LC; Kampman E; Mali WP; van der Graaf Y; Geerlings MI;
Alzheimers Dement; 2013 May; 9(3):302-9. PubMed ID: 22863909
[TBL] [Abstract][Full Text] [Related]
12. Brain structural change and gait decline: a longitudinal population-based study.
Callisaya ML; Beare R; Phan TG; Blizzard L; Thrift AG; Chen J; Srikanth VK
J Am Geriatr Soc; 2013 Jul; 61(7):1074-9. PubMed ID: 23796055
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine and progression of generalized small-vessel disease: the SMART-MR Study.
Kloppenborg RP; Geerlings MI; Visseren FL; Mali WP; Vermeulen M; van der Graaf Y; Nederkoorn PJ;
Neurology; 2014 Mar; 82(9):777-83. PubMed ID: 24477110
[TBL] [Abstract][Full Text] [Related]
14. Automated measurement of brain and white matter lesion volume in type 2 diabetes mellitus.
Jongen C; van der Grond J; Kappelle LJ; Biessels GJ; Viergever MA; Pluim JP;
Diabetologia; 2007 Jul; 50(7):1509-16. PubMed ID: 17492428
[TBL] [Abstract][Full Text] [Related]
15. Brain atrophy and cognition: interaction with cerebrovascular pathology?
Muller M; Appelman AP; van der Graaf Y; Vincken KL; Mali WP; Geerlings MI
Neurobiol Aging; 2011 May; 32(5):885-93. PubMed ID: 19520460
[TBL] [Abstract][Full Text] [Related]
16. Carotid atherosclerosis and progression of brain atrophy: the SMART-MR study.
Muller M; van der Graaf Y; Algra A; Hendrikse J; Mali WP; Geerlings MI;
Ann Neurol; 2011 Aug; 70(2):237-44. PubMed ID: 21674583
[TBL] [Abstract][Full Text] [Related]
17. Total cerebral blood flow, white matter lesions and brain atrophy: the SMART-MR study.
Appelman AP; van der Graaf Y; Vincken KL; Tiehuis AM; Witkamp TD; Mali WP; Geerlings MI;
J Cereb Blood Flow Metab; 2008 Mar; 28(3):633-9. PubMed ID: 17912270
[TBL] [Abstract][Full Text] [Related]
18. White matter lesions and lacunar infarcts are independently and differently associated with brain atrophy: the SMART-MR study.
Appelman AP; Vincken KL; van der Graaf Y; Vlek AL; Witkamp TD; Mali WP; Geerlings MI;
Cerebrovasc Dis; 2010; 29(1):28-35. PubMed ID: 19893309
[TBL] [Abstract][Full Text] [Related]
19. Cognitive dysfunction and its clinical and radiological determinants in patients with symptomatic arterial disease and diabetes.
Tiehuis AM; Mali WP; van Raamt AF; Visseren FL; Biessels GJ; van Zandvoort MJ; Kappelle LJ; van der Graaf Y;
J Neurol Sci; 2009 Aug; 283(1-2):170-4. PubMed ID: 19268970
[TBL] [Abstract][Full Text] [Related]
20. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in CADASIL.
Duering M; Zieren N; Hervé D; Jouvent E; Reyes S; Peters N; Pachai C; Opherk C; Chabriat H; Dichgans M
Brain; 2011 Aug; 134(Pt 8):2366-75. PubMed ID: 21764819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
